AI in Healthcare Digest

Executive Brief Drug discovery's AI moment is no longer theoretical — the field has crossed a threshold where organizations without AI infrastructure for target identification, compound screening, and clinical trial design are falling meaningfully behind. This analysis documents the shift from "AI as augmentation" to "AI as core platform."

Executive Brief Researchers at the University of Colorado Anschutz Medical Campus are developing a framework for trustworthy clinical AI — one built from clinician feedback, not deployed on top of it. Their work is a direct response to mounting evidence that AI tools adopted without clinical co-design often fail at the point of care.

Executive Brief The radiology AI landscape is quietly undergoing a more profound transformation than the headline numbers suggest: it's not just reading scans faster, it's predicting treatment response and recurrence before symptoms appear. The field is moving from diagnosis to prognosis — and clinicians are learning to work with tools that tell them what will happen, not just what already has.

Executive Brief A biotech-native perspective on where AI actually delivered in drug discovery last year — and where it didn't — with candid analysis of which trends are real and which are still waiting for the infrastructure to catch up. A useful reality check for anyone navigating vendor claims in this space.

Executive Brief The patient safety organization ECRI has put AI chatbots — ChatGPT, Gemini, Copilot — at the top of its annual health technology hazard list, ranking them more dangerous than cybersecurity breaches and medical device failures. The designation carries real weight: it signals that unregulated, unvalidated AI is reaching patients at scale with measurable harm potential, and that health systems need governance frameworks now, not later.

Executive Brief While health systems debate AI in clinical care, a different AI problem is emerging upstream: the hiring algorithms filtering nursing job applicants are systematically disadvantaging qualified candidates from underrepresented backgrounds. The result is a compounding crisis — AI is simultaneously being proposed as a solution to nursing shortages while making those shortages worse at the recruitment stage.

Executive Brief Austin-based Insight Health has closed an $11M Series A to expand its AI agent platform targeting clinical administrative work — patient screening, referral processing, and EHR documentation. With over 3 million autonomous patient interactions already processed and $50M+ in reported annualized savings for its clients, the company is making a case that AI agents can meaningfully automate the administrative layer of care delivery without requiring clinical staff replacement.

Executive Brief Hippocratic AI has raised $126 million in a Series C round at a $3.5 billion valuation — bringing total funding to $404 million — to expand its patient-facing AI agent deployments across health systems, payors, and pharma clients globally. The company is also building an acquisition war chest, signaling that consolidation in the healthcare AI agent space is accelerating.

Executive Brief SAS is bringing new healthcare and life sciences AI capabilities to its flagship Innovate conference, showcasing how enterprise analytics platforms are evolving to handle clinical decision support, population health management, and regulatory compliance — not just financial and operational reporting. It's a signal that traditional health IT vendors are competing aggressively in the AI space.

Executive Brief A sharp editorial from radiology AI company RAD AI is capturing wide circulation in health tech circles — its central argument: 2026 is the year the healthcare AI industry stops getting credit for potential and starts being judged on results. The piece is resonating because it names the frustration many health system leaders feel after years of expensive pilots with limited clinical ROI.

Executive Brief This HealthLeaders roundup of healthcare AI predictions is getting significant traction because it focuses not on what's theoretically possible but on what health system leaders are actually budgeting for and deploying right now — a rarer and more useful framing than most industry prediction pieces. It's being shared widely among CMIOs and CNIOs as a quick benchmark for their own roadmaps.